Walking balance is mediated by muscle strength and bone mineral density in postmenopausal women: an observational study by Ibeneme, Sam C. et al.
RESEARCH ARTICLE Open Access
Walking balance is mediated by muscle
strength and bone mineral density in
postmenopausal women: an observational
study
S. C. Ibeneme1,6,7* , C. Ekanem1, A. Ezuma2,6, N. Iloanusi3,6, N. N. Lasebikan3,6, O. A. Lasebikan4 and O. E. Oboh5
Abstract
Background: Depletion of ovarian hormone in postmenopausal women has been associated with changes in the
locomotor apparatus that may compromise walking function including muscle atrophy/weakness, weight gain, and
bone demineralization. Therefore, handgrip strength (HGS), bone mineral density (BMD) and body composition
[percentage body fat mass (%BFM), fat mass (FM), Fat-free mass (FFM) and body mass index (BMI)], may significantly
vary and predict WB in postmenopausal women. Consequently, the study sought to 1. Explore body composition,
BMD and muscle strength differences between premenopausal and postmenopausal women and 2. Explore how
these variables [I.e., body composition, BMD and muscle strength] relate to WB in postmenopausal women.
Method: Fifty-one pre-menopausal (35.74 + 1.52) and 50 postmenopausal (53.32 + 2.28) women were selected by
convenience sampling and studied. Six explanatory variables (HGS, BMD, %BFM, FFM, BMI and FM) were explored
to predict WB in postmenopausal women: Data collected were analyzed using multiple linear regression, ANCOVA,
independent t-test and Pearson correlation coefficient at p < 0.05.
Result: Postmenopausal women had higher BMI(t = + 1.72; p = 0.04), %BFM(t = + 2.77; p = .003), FM(t = + 1.77; p = 0.
04) and lower HGS(t = − 3.05; p = 0.001),compared to the premenopausal women. The predicted main effect of age
on HGS was not significant, F(1, 197) = 0.03, p = 0.06, likewise the interaction between age and %BFM, F(1, 197) = 0.
02, p = 0.89; unlike the predicted main effect of %BFM, F(1, 197) = 10.34, p = .002, on HGS. HGS was the highest
predictor of WB (t = 2.203; β=0.3046) in postmenopausal women and combined with T-score right big toe
(Tscorert) to produce R2 = 0.11;F (2, 47)=4.11;p = 0.02 as the best fit for the predictive model. The variance (R2)
change was significant from HGS model (R2 = 0.09;p = 0.03) to HGS + Tscorert model (R2 = 0.11;p = 0.02). The
regression model equation was therefore given as: WB =5.4805 + 0.1578(HGS) + (− 1.3532) Tscorert.
Conclusion: There are differences in body composition suggesting re-compartmentalization of the body, which
may adversely impact the (HGS) muscle strength in postmenopausal women. Muscle strength and BMD are
associated with WB, although, only contribute to a marginal amount of the variance for WB. Therefore, other factors
in addition to musculoskeletal health are necessary to mitigate fall risk in postmenopausal women.
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Background
Walking balance (WB) was operationalized as walking in
an upright position without the elicitation of equilibrium
reactions/wavering [1]. This mechanism which is oper-
ationally deployed to stabilize the body can be compro-
mised from the consequent effects of aging such as
weakness in bone, changes of body composition [in-
creased percentage body fat mass (%BFM), increased fat
mass(FM), decreased Fat-free mass(FFM) and increased
body mass index (BMI)] and muscle status in postmeno-
pausal women [2–4]. The handgrip strength (HGS) pro-
vides a measure of the changes in muscle status, general
health status and serves as a predictor of other health
conditions likely to impact WB, although it is not the
causative factor [5, 6]. Importantly, HGS has a positive
relationship with bone mineral density (BMD) in post-
menopausal women [7]. Invariably, there could be a link
between body composition, HGS, BMD and WB, which
needs to be considered when making clinical decisions
about menopause. Therefore, the objectives of the study
are to 1. Explore body composition, BMD and muscle
strength differences between premenopausal and post-
menopausal women and 2. Explore how these variables
[I.e., body composition, BMD and muscle strength] re-
late to WB in postmenopausal women.
Menopause is a transition period, which is a function
of aging and usually occurs in the age range of 42–
58 years [8, 9]. It is characterized by psychosocial reor-
ientation(mood disorders - anxiety and depression re-
lated to body image and self-esteem), sociological
changes (due to loss of reproductive function, dimin-
ished sexual function and perception of self-worth/rele-
vance in relationships) and anxiety-related physiological
variations (symptoms – such as sweating, and hot
flushes resulting in increased muscle fatigue and feelings
of lethargy) [9, 10] that accompany the depletion of the
ovarian hormones [11]. Such symptoms as depression
and fatigue may negatively impact the physical activity
level of postmenopausal women, especially walking func-
tion. In addition, postmenopausal estrogen decrease has
been linked with several physiologic changes in the body
composition including increase in fat mass, increased vis-
ceral adiposity and BMI [12] Overall, there is a decrease in
lean body mass or FFM [13], BMD and HGS [14, 15].
Meanwhile, an increase in the BMI or body mass (BM) at
the same or constant height (ht), implies a relative in-
crease in body weight (load) or BM since BMI = BM/ ht2;
BM= FM+ FFM [16]. A concomitant decrease in FFM
and HGS (muscle strength) in postmenopausal women
not only suggests a recompartmentalisation/change in
body composition, but also a mismatch between body
weight (load) and muscle strength available to influence it,
which is a common feature of fallers [17, 18]. Invariably,
with increasing weight gain, an individual with weakened
or fatigued muscles, which is common in postmenopausal
women [9–11, 14, 15], will likely be progressively unstable
and prone to fall in upright stance [17, 18]. Therefore, a
match between body weight and available muscle strength
may be a critical factor for postural stability, which may
have implications for WB in postmenopausal women. This
may help to explain why body weight is a predictor of pos-
tural stability [19]. In this context, postural stability was
operationalized as an individual’s ability to maintain a
state of equilibrium without swaying, staggering or reeling
and thus minimize the tendency to fall. Invariably, factors
that impact postural stability such as body weight, and
muscle strength, should have a predictive effect on WB. It
was, therefore, predicted that body composition, HGS,
and BMD might explain variance in WB among postmen-
opausal women.
Method
Five hundred and sixty-four consenting female staff of
the University of Nigeria Teaching Hospital (UNTH),
Ituku/Ozalla, Enugu, who were identified from the hos-
pital telephone directory were targeted in a cross-
sectional observational study. The UNTH Enugu was se-
lected because many studies have been done on meno-
pause in this hospital community, [2] and therefore
allows for contextual interpretations of the findings rela-
tive to previous studies. Fisher’s equation was used to
determine the sample size for the study with reference
to the estimated national menopause prevalence of 3.6%
giving a sample size of 58 participants. This is reason-
able, since 0–3 patients per month seen by gynecologists
across Nigeria, presented with symptoms of menopause
[20], and 1% prevalence rate of premature menopause
have been previously reported [21].
The 564 female workers, on the hospital’s phone direc-
tory, were contacted via email that explained the pur-
pose of the study while soliciting for their participation
(Fig. 1). A follow-up contact phone calls were made by 4
research assistants using the hospital’s phone directory
and only 303 female workers with right-handed/limb
dominance, indicated willingness to participate in the
study and were enlisted. The participants that met the
eligibility criteria, for the study, were subjected to vari-
ous physical assessments likewise their walking balance.
Five inclusion criteria were applied as follows: - At least
1-year regular menstrual cycle, prior to the study, for
women at pre-menopause, Non-menstruation for at least
one year; for in postmenopausal women, 3) No history
of other diseases of metabolic, neurologic or orthopedic
nature, 4) Age not < 25 but not > 64 years; and 5) Only
right-handed (i.e. left cerebral dominance) individuals
were recruited, This is important, because handedness
may influence HGS and subsequent skeletal loading/
traction on the bone during physical activity may
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influence the BMD [22]. Moreover, since right-hand
dominance was found to be at 92.6% in boys and at
91.9% in girls [23], it will be easier to recruit equivalent
groups of pre-and postmenopausal women. Therefore,
lack of consideration for handedness may be a reason-
able threat to internal validity of the study and may not
provide a reference or basis that may be required when
comparing the findings of the study with similar works
in the literature.
Exclusion criteria: -
1. Individuals on bisphosphonates, steroids or other
drugs which could influence bonemetabolism/
mineral density [24], were not eligible, and
2. Individuals with comorbid conditions that may
affect bone health (e.g. CHF, renal failure and
cancer) [25–27] were not eligible.
This population was further categorized based on their
menopausal status, using the information they provided
in a self-reported proforma. According to Ibeneme et al.
[2], menopausal statuses was classified into 4: 1) pre-
menopausal: regular menstrual cycles; 2) peri-
menopausal: ≥3 months without menses, large changes
in cycle length and hot flashes; or 3) post-menopausal:
≥12 months without menses and had undergone a hys-
terectomy. or 4) post-menopausal: ≥12 months without
menses and had not undergone a hysterectomy. Based
on this classification, 81 premenopausal women and 78
postmenopausal women, who have not undergone hys-
terectomy, were identified and required to further indi-
cate whether they have used estrogen. From the data
they provided, they were subsequently categorized into 4
groups: i. Never used estrogen, ii. Used estrogen for
≤5 years, iii. Used estrogen for ≥5 years and iv. Not sure
of ever using estrogen. Only those who never used estro-
gen were drawn into the sample comprising 76 premen-
opausal women and 83 postmenopausal women. Of this
number, only those that provided signed written in-
formed consent were selected for the study, and com-
prised 50 premenopausal and 51 postmenopausal
women, respectively.
Fig. 1 Design and flow of participants through the study
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The study process comprised three stages: obtaining
informed consent, physical assessment and measure-
ment of walking balance. The test instruments were: -
i. Fat Loss Monitor with Scale (OMRON® HBF-400): -
The equipment measures Weight: 0.0 lb. to 330.0
lbs. in 0.2 lb. increments; %BFM: 5.0 to 60.0% in
0.1% increments; and BMI: 7.0 to 90.0 in 0.1 incre-
ment. DEXA (Dual Energy X-Ray Absorptiometry)
has been the established method for accurate
evaluation of body composition. OMRON has used
research information from several hundred people
from 10 to 80 years of age using the DEXA method
to develop the formula by which the Fat Loss
MONITOR with Scale works. The body fat mass
and body fat percentage are calculated by a formula
that includes five factors: electrical resistance, height,
weight, age and gender.
ii. Hand Dynamometer (Lafayette, model 78,010, USA).
This equipment features a dual- scale readout that
displays isometric grip force from 0 to 200 pounds
(0–100 kg). The HGS was read off to the nearest
1.0 kg.
iii. Stadiometer: - The height was read off and recorded
to the nearest 1.0 cm at the vertex of the head with
the participants standing barefoot.
iv. Measuring tape (butterfly brand, made in China): A
15 m long measuring tape was used to mark out the
required 3-m distance on the ground.
v. Stop clock (Heurer brand, made in Germany). The
stop clock was used to measure the walk time
required to cover the 3-m distance and was read off
to the nearest second.
vi. Weighing scale (Hana bathroom scale, made in
China) – This was used to obtain the weight of the
subjects. The body weight was read off to the
nearest 1.0 kg.
Data collection
The 4 research assistants were trained on specific assess-
ment procedure to ensure consistency in measurement
and minimize inter-observer errors. Thus, one assistant
was trained specifically for any of the four assessment
tasks, namely i. Measurement of the BMD, ii. HGS, iii.
Body composition [%BFM, FFM, BMI and FM], height,
and, iv. WB. A pilot study was subsequently conducted
at the University of Nigeria, Enugu Campus to ensure
that the research assistants were acquainted with the test
instruments and relevant operational procedures prior
to the study.
Procedures for the study were explained to the partici-
pants and only those that gave their written informed
consent were involved in the study. Participants’ an-
thropometric data were measured, including weight and
height. The data generated were imputed into the bio-
impedance electronic Fat Loss Monitor with Scale
(OMRON® HBF-400) for each individual. They were re-
quested to stand barefoot on the equipment with their
feet, clean and dry. Participants were asked to position
their feet on the electrodes and make sure each of the
heels is positioned on a heel electrode, with weight
evenly distributed on the measurement platform. They
were asked to remain still and not move until the meas-
urement is complete and readings of their body compo-
sitions were displayed on the LCD screen. Thereafter,
Hume’s formula [(0.29569*W) + (0.41813 * HT) –
43.2933. Where W =weight, HT = height] [28, 29] was
used to calculate the lean muscle mass or FFM.
The HGS was subsequently measured using a dyna-
mometer as prescribed by American Society for Surgery
of the Hand and the American Society of Hand Thera-
pists, which is described in detail elsewhere [30]. The
grip strength was determined with the subjects in a sit-
ting position, and with the shoulder adducted and neu-
trally rotated, while the elbow was flexed to 90 degrees,
and the forearm and wrist held in a neutral position.
The two arms (immovable and moveable) were adjusted
to zero from the onset. The subjects were then asked to
grip the equipment and sustain it for 1 min. The move-
able arm was displaced according to the strength of the
grip and came to rest at the point of maximum grip
strength. The difference between the position of the im-
movable arm and the position of the moveable was de-
termined as the value of the hand grip strength. Three
trials were carried out for right dominant hand and the
mean was determined and recorded.
Subsequently, the participants’ WB was assessed using
the ‘Timed Up & Go Test’ [31]. Each participant was
asked to sit in a chair and from which they were re-
quired to rise with the command - “ready, set, go.” Then,
the participants were required to walk forward over a 3-
m (10 ft) distance and back to the chair. The Stop clock
was stopped and the time was recorded on completion
of the task. The BMD of the right and left Hallux (i.e.
big toe), in right-handed individuals, was measured using
the Xrite 331C densitometer. To Null the instrument,
the following steps apply 1. Remove film from reading
area.2. Lower the reading arm. Press the “NULL” button
and hold while pressing the “MEASURE” button. 3. Hold
both buttons down until the reading on the display has
stabilized. Thereafter, the absolute density was measured
as follows: 1. Null the instrument as previously de-
scribed., 2. Center the film area in question directly over
the aperture under the reading arm.3. Lower the reading
arm. Press the “MEASURE” button and hold for a few
seconds until the lamp goes out. 4. Remove pressure on
the MEASURE button so that the reading arm rises. The
density measured will be displayed until the button is
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pushed again. To compare the density readings, the fol-
lowing steps apply 1. Place reference film over the aper-
ture. Null the instrument as previously described. 2.
Place the film to be compared over the aperture and
measure the density. This measurement is the difference
between the reference film density (2.99dens) and the
compared film density. A minus (−) display indicates the
compared film is a lower density. Normal: Bone density
is within 1 SD (+ 1 or − 1) of the young adult mean. Low
bone mass (osteopenia): Bone density is 1 to2.5 SDs
below the young adult mean (− 1 to − 2.5 SD). Osteopor-
osis: Bone density is 2.5 SDs or more below the young
adult mean (less than − 2.5 SD) [32].
Data/statistical analysis
Multiple linear regression analysis was conducted to as-
sess the effect of the six explanatory variables (HGS,,
%BFM, FFM, BMI, FM and T-score of the right big
toe(T-scorert) on WB, in postmenopausal women, after
adjustment for age [33], smoking status [34], level of
physical activity [35], alcohol intake, [36, 37] vitamin K
intake, [38] comorbid conditions (e.g. chronic heart fail-
ure, renal failure and cancer) [25–27] and drug interac-
tions (e.g. amiodarone, statins, non-steroidal anti-
inflammatory drugs, antiplatelet agents) [39, 40]. Three
explanatory models were proposed to explain the vari-
ance in WB among postmenopausal women, namely, i.
HGS model, ii. HGS + %BFM model and iii. HGS
+ %BFM +T-scorert model. Based on an ordinary least
square (OLS) regression analysis of these models, non-
significant interactions and predictors were removed.
The explanatory variables in a multiple linear regression
equations should be independent of one another [41]. If
two or more explanatory variables are correlated, that is,
if their regression lines are parallel or “collinear,” then
they are not independent. Collinear variables add much
the same information to the model, so only one is
needed. The variable with the strongest relationship with
the response variable (WB) should be considered for in-
clusion in the final model. Analysis of covariance
(ANCOVA) was used to predict the main effects of age
on HGS and its interaction effects with %BFM. Faculty
Vassar computational website software was used for the
data analysis. Alpha was set at p < 0.05.
Results
The design and flow of participants through the study is
shown in Fig. 1. The results of this study showed that
(Table 1) the postmenopausal women were significantly
(p < 0.05) older, shorter in height and with greater BMI
than the premenopausal women. In contrast, there was
no significant (p > 0.05) difference in body weight of the
postmenopausal women compared to the premeno-
pausal women. Analysis of the body composition
(Table 2) showed that the postmenopausal women had
significantly (p < 0.05) higher %BFM and FM compared
to the premenopausal women. However, there was no
significant difference (p < 0.05) in the FFM between both
groups. Furthermore, the premenopausal women had
significantly (p < 0.05) higher HGS than the postmeno-
pausal women. The predicted main effect of age on HGS
was not significant, F(1, 197) = 0.03, p = 0.06, unlike the
predicted main effect of %BFM, F(1, 197) = 10.34,
p = .002. The interaction between age and %BFM were
also not significant, F(1, 197) = 0.02, p = 0.89. Test for
homogeneity of regressions was not significant, F(3,
197) = 0.76, p = 0.52. Overall, there was no significant
(p > 0.05) group difference in WB when postmeno-
pausal women were compared to the premenopausal
women (Table 3). Similarly, T-score (Table 4) for the
right and left toe did not differ significantly (p > 0.05)
in the postmenopausal women compared to premeno-
pausal women.
Basic descriptive statistics and regression coefficients
are shown in Tables 5, 6 and 7. For body composition,
multicollinearity of the explanatory variables was evident
since the FFM, FM, BMI, and %BFM were correlated.
Given that the %BFM is the measure of body compos-
ition with the strongest correlation (r = 0.061) with WB,
FFM (r = 0.02), FM (r = 0.055) and BMI (r = 0.03) were
removed from the model. Thus, the subsequent sequential
multiple linear regression analysis was employed to pre-
dict WB in postmenopausal women from %BFM, HGS
Table 1 Anthropometric Characteristics of premenopausal (N = 51) and Postmenopausal (N = 50) women
Menopausal
status
Age Height Weight Body mass index
X ± SD Range X ± SD Range X ± SD Range X ± SD Range
Pre-menopause 35.74 ± 1.52 27–49 1.63 ± 2.33 1.47–1.8 73.09 ± 4.52 50.6–100.9 27.47 ± 1.62 18.6–42.1
Post-menopause 53.32 ± 2.28 42–71 1.60 ± 2.05 1.35–1.76 75.01 ± 4.74 47.3–129 29.49 ± 1.72 18.8–40.1
Mean difference 17.57 ± 2.70 −3.45 ± 3.08 1.92 ± 6.49 2.02 ± 2.34
t-value + 12.93 −2.23 + 0.59 + 1.72
df 99 99 99 99
p-value one tailed < 0.0001*** 0.01* 0.28 0.04*
*Indicates significance at p < 0.05; ***indicates significance at p < 0.0001
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and T-scorert. HGS was the highest predictor of WB(t =
2.203; β=0.3046) in postmenopausal women (Table 5).
Based on our earlier predictions, on the first step, the
HGS was entered into the model. It was significantly corre-
lated with WB (R2 = 0.09; Adjusted R2 = 0.07; Std error of
estimate = 5.53; F (1, 48) = 4.86; p = 0.03). On the second
step (Table 5), T-scorert was entered into the model result-
ing in significant increase in R2 = 0.15; Adjusted R2 = 0.11;
Std error of estimate = 5.35; F (2, 47) = 4.11; p = 0.02).
Thereafter, the remaining predictor (i.e. %BFM) was en-
tered into the model (Tables 6 and 7) resulting in no signifi-
cant increase in R2 = 0.15; Adjusted R2 = 0. 10; Std error of
estimate = 5.34; F (3, 46) = 2.72; p = 0.06. Since the level at
which R2 reaches a maximum and decreases afterward,
would be the regression with the ideal combination of hav-
ing the best fit and since the full model R2 was not signifi-
cantly greater than zero when the three predictor variables
were combined, the best fit was therefore realized when
only two predictor variables - HGS and T-scorert - were
combined. The regression model equation for predicting
WB in postmenopausal women was therefore given as WB
=5.4805 + 0.1578(HGS) + (− 1.3532)T-scorert.
Discussion
Relevance of findings to the field
There are differences in body composition between pre-
menopausal and postmenopausal women suggesting a
re-compartmentalization of the body. For instance, des-
pite the similarity in the BMI range and category for
both groups, the %BFM, FFM, BMI and FM were
significantly higher but not the FFM, among postmeno-
pausal women than the premenopausal women. Similar
findings have been reported elsewhere by previous au-
thors [2, 3] .Based on the p-values, it was projected that
postmenopausal changes might have a more profound
impact on the %BFM compared to FM. Therefore, fat
re-distribution might be more sensitive to postmeno-
pausal changes than the overall FM [42, 43] Invariably, fat
adiposity in postmenopausal women might be an import-
ant difference that may have greater clinical implications
for health. Already, fat adiposity has been strongly associ-
ated with C-reactive protein - a major biomarker of sys-
temic inflammation, which lies on the biological pathways
to some non-communicable diseases [44, 45] that may
affect bone health.
Importantly, a significantly higher %BFM could be an
indication of a relatively lower FFM or lean muscle mass
if the body mass was constant. This is plausible since
BM =%BF + FFM and therefore translates to a propor-
tionate or relative weakening of the skeletal musculature
required for ambulation and balance control. Given that
postmenopausal changes are age-related [8] it was ex-
pected that age might likewise have significant negative
effects on HGS and therefore contribute to a weakened
musculature in postmenopausal women. On the con-
trary, ANCOVA analysis revealed that the main predi-
cated effects of age on HGS was not significant likewise
its interaction effects with %BFM. However, %BFM sig-
nificantly affected HGS. Therefore, differences in the
body composition, especially %BFM, in postmenopausal
women compared to premenopausal women might
partly explain why the HGS of the former was signifi-
cantly weakened than the later. Since the skeletal muscle
is part and parcel of the locomotor apparatus [2, 17, 18]
,the significantly weakened muscle strength may also sig-
nificantly impact WB [2] and may help to explain its
variance in postmenopausal women.
Muscle atrophy has been reported in postmenopausal
women [46] and may partly explain the significantly
weakened HGS observed in this population relative to
premenopausal women, in this study. The significantly
lower HGS (muscle strength) combined with signifi-
cantly higher BMI (load) in postmenopausal women
Table 2 Variations in body composition and handgrip strength in premenopausal (N = 51) and postmenopausal (N = 50) women
Menopausal status %Body fat Fat mass Fat-free mass Handgrip strength
Pre-menopause 22.41 ± 2.16 17.32 ± 2.49 45.92 ± 1.86 35.10 ± 3.80
Post-menopause 26.22 ± 6.05 20.42 ± 2.51 46.55 ± 2.17 27.57 ± 3.18
Mean difference 3.82 ± 3.89 3.10 ± 3.50 −0.62 ± 4 −7.52 ± 4.91
t-value + 2.77 + 1.77 −0.44 −3.05
df 99 99 99 99
p-value one tailed 0.0033** 0.04* 0.3304 0.0015**
*Indicates significance at p < 0.05; **indicates significance at p < 0.001
Table 3 Variations in Static balance and walking balance in in
premenopausal (N = 51) and Postmenopausal women (N = 50)
Menopausal status Static balance Walking balance
Pre-menopause 3.30 ± 0.52 9.76 ± 0.47
Post-menopause 4.65 ± 1.33 10.88 ± 5.80
Mean difference 1.35 ± 1.40 1.12 ± 4.43
t-value + 1.92 + 1.32
df 99 99
p-value one tailed 0.03* 0.09
*Indicates significance at p < 0.05
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compared to premenopausal women, may suggest a rela-
tive increase in limb loading. This may lead to a misrela-
tion between the load and available muscle strength,
which might create a more difficult operational condi-
tion for the locomotor apparatus.
Implications for care teams and policymakers
Correlation and multiple regression analyses were con-
ducted to examine the relationship between body com-
position (%BFM, FFM BMI and FM), muscle strength
(HGS), BMD (T-scorert) and WB. The HGS + %BFM +
T-scorert predictive model, produced R2 = 0.0467; F (7,
42)=1.34; p = 0.256 R2 = 0.15; Adjusted R2 = 0. 10; Std
error of estimate = 5.34; F (3, 46) = 2.72; p = 0.06. This
model could only explain 10% of the variance in WB
when adjusted for other confounders. The model with
the best fit is HGS + T-scorert model, which produced
R2 = 0.15; Adjusted R2 = 0.11; Std error of estimate =
5.35; F (2, 47) = 4.11; p = 0.02 and explained 11% of the
variance in WB, when adjusted for the confounding vari-
ables. Nevertheless, the proportion of variance is small
suggesting that other factors might also explain the vari-
ance in WB. Overall, the BMD is not a good predictor
of WB in postmenopausal women, hence those ratings
had little to offer compared to HGS in relation to WB,
in the predictive model. Therefore, interventions that
increase BMD may predispose to fail without a comple-
mentary muscle strengthening program. This view is
reasonable and is supported by previous evidence [47,
48]. It was recognized, however, that the BMD assess-
ment may provide the clinicians with valuable informa-
tion on the potential effects of menopause on bone
health which is not considered in the analysis reported
here. It must also be considered that the postmeno-
pausal women may gain valuable information about
bone health during BMD assessment - an information
which may help them better re-evaluate their subsequent
lifestyle including physical activity level, medication and
nutrition.
The broader implications of these findings could also
have translational relevance in clinical practice and man-
agement of osteoporosis or fall in postmenopausal
women. It will mean that when the BMD of postmeno-
pausal women is improved using medications/nutrition,
there must be a complimentary build-up of muscle
strength using relevant therapeutic exercises to enhance
WB. This is important, because only the HGS (muscle
strength) out of the three explanatory variables, is sig-
nificantly and positively correlated with the WB. It indi-
cates that those with higher mean scores on HGS may
Table 4 Variations in bone mineral density and Tscore in premenopausal (N = 51) and Postmenopausal (N = 50) women
Menopausal
status
Right Toe Left Toe
BMD T Score BMD T Score
Pre-menopause 2.38 ± 0.22 −0.59 ± 0.22 2.20 ± 0.19 −0.61 ± 0.19
Post-menopause 2.19 ± 0.29 −0.78 ± 0.29 2.39 ± 0.18 −0.76 ± 0.19
Mean difference −0.19 ± 0.36 −0.18 ± 0.36 − 0.19 ± 0.26 −0.15 ± 0.26
t-value −1.04 − 1.00 − 1.49 − 1.16
df 99 99 99
p-value one tailed 0.15 .16 0.07 0.12
BMD = bone mineral density; Tscore = Standardized bone mineral density score relative to sex and age
Table 5 The Estimated Regression Coefficients for the two
explanatory variables Entered into the Model for
postmenopausal women (N = 50)
Zero-Order r
Variables Tscorert HGS WB β t b
HGS 1 0.303* 0.3046* 2.203 0.1578
Tscorert 1 0.01 −0.237* − 0.2386* −1.69 − 1.3532
Mean 2.19 27.57 10.88
SD 0.29 3.18 5.80 R2 = 0.1489
*p < .05; Tscorert = Standardized bone mineral density score for right big toe;
HGS = Handgrip strength; %BFM = Percentage body fat mass; WB =Walking
balance; Multiple R2== 0.1489; Adjusted Multiple R2 = 0.1126; std. error of
estimate = 5.3492; F (2, 47)= 4.11; p = 0.023*; a = 5.4805. In postmenopausal
women, the regression Model equation
for WB = 5.4805 + 0.1578(HGS) + (− 1.3532)Tscorert
Table 6 Three explanatory variables related to walking balance
in postmenopausal women (N = 50)
Zero-Order r β b
Variable %BFM HGS Tscorert WB
Tscorert −.24 −.24 −1.3481
HGS 0.01 .30 .30 . 1568
%BF 0.04 −0.02 .06 .04 . .0406
Intercept = 4.4452
Mean 26.22 27.57 2.19 10.88
SD 6.05 3.18 0.29 5.80 R2 = . .1506
Tscorert = Standardized bone mineral density right big toe; HGS = Handgrip
strength; %BFM = Percentage body fat mass; WB =Walking balance; Adjusted
Multiple R2 = 0. 0953, Std. Error of Multiple Estimate = 5.3436; F(3, 49) = 2.72; p
= 0. 0552; Regression model equation for Walking balance = 0.0406 (%BF) + 0.
1568 (HGS) + −1.3481 (Tscorert)
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tend to have higher or improved WB. Consequently, in-
terventions targeted at improving the muscle strength
(HGS) may improve limb loading likewise WB in post-
menopausal women.
Strength and limitations of study
The present study holds strength in the diverse nature
of the sample. The effects of muscle strength, body com-
position and BMD on WB in postmenopausal women,
was simultaneously investigated in a very large and well-
described hospital community. The hospital-based de-
sign allowed simultaneous presentation of findings from
health and non-health workers with diverse lifestyles,
views, opinions and experiences. Moreover, many studies
have been done on menopause in this hospital commu-
nity (i.e. the UNTH Enugu) [2, 21], and therefore allows
for contextual interpretations of the findings relative to
previous studies. The application of appropriate statis-
tical control of the effects of covariates, such as age, on
muscle strength relative to %BFM, may minimize the
threats to the validity of its findings. However, the self-
reported period of menopause is certain to include recall
error or even bias which may affect the accuracy of the
information provided by the participants. In addition,
the cross-sectional nature of the study makes it difficult
to infer causality between muscle strength, body com-
position, BMD and WB, respectively. Over time, as a
woman transits from premenopausal to postmenopausal
status, longitudinal observations on muscle strength,
body composition, BMD and WB would be possible, but
were not explored in this study. In spite of these limita-
tions, the strengths of the study suggest that it has both
scientific and practical implications.
Conclusion
Muscle strength is the highest predictor of WB and has
a significant positive regression weight, indicating that
postmenopausal women with greater muscle strength
were expected to have better WB. The BMD was not
significantly lower in postmenopausal women than pre-
menopausal women, but the variance (R2) change was
significant from HGS model to HGS + BMD model.
However, the proportion of variance in WB explained by
this model is small. Invariably other factors, such as psy-
chosocial, physiological and sociological variables, apart
from, musculoskeletal health may be necessary to im-
prove WB and mitigate fall risk in postmenopausal
women. A wholistic management may, therefore, entail
broader clinical considerations for other options such as
physical exercises, counseling, and psychotherapy, in
addition to medication, nutrition and musculoskeletal
health.
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